“…Restriction-deficient mutants (115) and broad-host-range plasmids (64,75,126,135) and phage vectors (208), including a bifunctional cosmid for use with S. rimosus, have also become available (40). These genetic tools and procedures have been applied to study the genetic instability of S. rimosus strains (49,80) and for the molecular cloning and characterization of the OTC resistance gene(s) (37,61,167,198) as well as the cloning of genes involved in OTC biosynthesis (29,36,37,150,177). These genes have also been used for the formulation of design rules for constructing hybrid aromatic polyketide synthases with a view to producing structural analogues, by combinato- rial biosynthesis, with potentially novel biological activities which are difficult to produce by traditional synthetic routes (125,148,175,177).…”